KZA — Kazia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Kazia Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2019 June 30th	2020 June 30th	R2021 June 30th	R2022 June 30th	2023 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5.43	8.76	27.6	7.36	5.24
Net Total Accounts Receivable
Net Total Receivables	1.71	1.35	0.084	0.091	3.9
Prepaid Expenses
Total Current Assets	7.51	10.7	29.4	9.45	10.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	—	—	—	—
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	21.2	23.1	57.1	35.9	28.1
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.9	5.07	5.95	6.73	7.57
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	6.98	8.94	19.2	17.6	16
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	14.2	14.1	37.9	18.3	12.1
Total Liabilities & Shareholders' Equity	21.2	23.1	57.1	35.9	28.1
Total Common Shares Outstanding